ETF PROAI
KUREKraneSharesINDEX

KraneShares MSCI All China Health Care Index ETF

$19.25+2.44% vs prior close
14.522152-WK

Price through Sep 30 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Sep 30. Holdings snapshot retrieved Sep 30.

The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.

Price & daily flows
19.9617.9816.0119.25DAILY NET FLOWSep 30Jan 29May 29Sep 30

SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 3Y SHOWN

The desk’s read

Recent fund-flow records are unavailable, while the price has returned +13.0% so far this year. At 0.65% a year it is not the cheapest way in — JDOC has a reported fee of 0.65%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$38Massets under management
0.65%expense ratio · $65 per $10,000 a year
—net flow, trailing month
56Kavg daily volume, 30 days
82holdings · US-domiciled
2018listed January 31, 2018 · beta 0.83
Sector weights
Healthcare98.46%
Health Technology86.79%
Health Services4.25%
Commercial Services3.46%
Distribution Services2.56%
Process Industries2.06%
Consumer Discretionary0.91%
Consumer Defensive0.89%
Consumer Non-Durables0.85%
Materials0.82%
PORTFOLIO COMPOSITION, LATEST DISCLOSURE
Country weights
China93.77%
United States3.84%
Other3.07%
Hong Kong2.39%
United Kingdom0.6%
PORTFOLIO COMPOSITION, LATEST DISCLOSURE
Performance
1 week+2.8%
1 month+3.2%
3 months+17.0%
6 months+12.8%
YTD+13.0%
1 year-10.3%
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week—
1 month—
3 months—
YTD—
1 year—

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

The risk read
33%realized volatility, 30 days (annualized)
28%realized volatility, 1 year
-32.3%deepest fall from a peak, 1 year
-10.3%latest close versus that peak

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
—calls · latest snapshot
2puts · latest snapshot
—put/call ratio
56Kshares traded
The case against KURE

Due diligence cuts both ways. These funds sit on the same shelf and beat KURE on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
SPDW State Street SPDR Portfolio Developed World ex-US ETF0.03%$41.5B+$286M-62bp on fee · 1080× the assets · +$286M in over the monthHead-to-head
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.03%$18.2B+$199M-62bp on fee · 473× the assets · +$199M in over the monthHead-to-head
IDEV iShares Core MSCI International Developed Markets ETF0.04%$32.9B+$497M-61bp on fee · 856× the assets · +$497M in over the monthHead-to-head
IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF0.04%$23.7B+$575M-61bp on fee · 616× the assets · +$575M in over the monthHead-to-head
IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF0.04%$18.6B+$412M-61bp on fee · 484× the assets · +$412M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.
InstrumentsHarvest substitutesTrade cost at $1MClient tearsheetStress this fund
THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.